Dr. Sreedhar A. Mandayam, MD
- Medicare services, 2024
- 792
- Medicare patients, 2024
- 345
- Part D claims, 2024
- 334
- Publications
- 45
- Clinical trials
- 5
- Practice address
- 1515 Holcombe Blvd, Houston, TX 77030
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Find Dr. Mandayam's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Sreedhar A. Mandayam is a nephrologist in Houston, Texas
Dr. Mandayam practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.
Dr. Mandayam's NPI, 1225051048, was assigned on July 25, 2006. Dr. Mandayam graduated from Bangalore Medical College in 1995. Dr. Mandayam's Texas license number on file is N3861.
- NPI
- 1225051048NPI Registry (opens in a new tab)
- Medicare PAC ID
- 7911901756
- NPI enumeration date
- July 25, 2006
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 57
- Medical school graduation
- 1995
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Sreedhar A. Mandayam practices at The University of Texas MD Anderson Cancer Center in Houston, Texas
Dr. Mandayam's primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.
- The University of Texas MD Anderson Cancer Center1515 Holcombe Blvd, Houston, TX 77030
Source: Dmand AI Affiliation Data
Dr. Sreedhar A. Mandayam is affiliated with 1 site of care and 3 medical groups
Dr. Mandayam's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. The medical group on file is Physicians Referral Service. Dmand AI also links Dr. Mandayam to 2 more medical groups, each named with a free account.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Sreedhar A. Mandayam's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mandayam practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| The University of Texas MD Anderson Cancer Center | Available with a free account |
| +2 medical groups | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across The University of Texas System and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Sreedhar A. Mandayam is one of 1,045 nephrologists in Texas
Nephrology is Dr. Mandayam's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Mandayam is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Mandayam's licenses on file in 10 states: Texas, Florida, Tennessee, Mississippi, Oklahoma, Washington, Alabama, Arizona, Georgia and Louisiana.
Specialties and state licenses
- Nephrology, TexasPrimary
- Florida license
- Tennessee license
- Mississippi license
- Oklahoma license
- Washington license
- Alabama license
- Arizona license
- Georgia license
- Louisiana license
Clinical focus
Dmand AI lists acute kidney failure, chronic kidney disease, fluid and electrolyte imbalances and kidney disease among the conditions Dr. Mandayam treats.
Nephrologists near Dr. Mandayam
Counts of nephrologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Sreedhar A. Mandayam billed Medicare for 792 services in 2024
CMS data shows 792 Medicare services from Dr. Mandayam across 7 procedure codes in 2024, for 345 Medicare patients. Medicare paid $85,521 for them.
Dr. Mandayam's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 7152024: 713No change
- Tests and treatments
- 2023: 732024: 798%
Where Dr. Mandayam's Medicare services took place, 2024
- In an office466%
- In a facility74694%
Dr. Mandayam compared with the Texas median for nephrologists, 2024
- Dr. Mandayam
- Texas median
- Medicare services
- 792vs 1,04824% below
- Medicare patients
- 345vs 27725% above
- Part D claims
- 193vs 75875% below
Medians across 1,017 nephrologists in Texas with Dmand AI profiles that report each measure.
Dr. Mandayam's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Mandayam?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Mandayam and other nephrologists in Texas.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Sreedhar A. Mandayam treated 345 Medicare patients in 2024, average age 71
CMS counts 345 Medicare patients who saw Dr. Mandayam in 2024. The largest group is 65 to 74, with 172 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 8% are also on Medicaid. Their average risk score is 4.05, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Mandayam's median patient age at 71, with 37% women.
Dr. Mandayam's Medicare patients by age, 2024
Dr. Mandayam's Medicare patients by sex, 2024
- Women12235%
- Men22365%
Chronic conditions among Dr. Mandayam's Medicare patients, 2024
- Chronic kidney disease75%
- High blood pressure75%
- High cholesterol75%
- Cancer52%
- Arthritis51%
- Diabetes50%
- Ischemic heart disease50%
- Heart failure43%
Share of Medicare patients with each condition. A patient can have several.
Dr. Mandayam's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 71
Patient panel by sex, all payers
- Women37%
- Men60%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Sreedhar A. Mandayam wrote 334 Medicare Part D claims in 2024
In 2024, Dr. Mandayam wrote 334 Medicare Part D claims for 65 patients. 78% of them were for generic drugs. CMS names the drug for 193 of them, across 8 drugs with 11 or more claims each, at $46,243 in total drug cost. In 2023, CMS named 124 claims across 6 drugs.
Dr. Mandayam's Part D claims by kind of drug, 2024
- Generic259 claims78%
- Brand-name75 claims22%
Dr. Mandayam's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 1242024: 19356%
Drugs named by CMS: 8 in 2024, 6 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Sreedhar A. Mandayam offers telehealth to Medicare patients
Dr. Mandayam accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mandayam as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Source: Doctors and Clinicians National Downloadable File (CMS)
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Sreedhar A. Mandayam has 45 publications on record
Dmand AI links 45 papers to Dr. Mandayam, published from 2007 to 2025. 2017 was the busiest year, with 10. The most frequent topics are Renal Insufficiency, Chronic, Kidney Failure, Chronic and Renal Dialysis. Dr. Mandayam has published most often in Am J Kidney Dis. Dr. Mandayam's most frequent co-authors are Wolfgang C. Winkelmayer, DSC, MD, Chandan Vangala, MD and Sankar Dass Navaneethan, MD.
Dr. Mandayam's papers by year, 2015 to 2025
Topics Dr. Mandayam writes about most
- Renal Insufficiency, Chronic
- Kidney Failure, Chronic
- Renal Dialysis
- Acute Kidney Injury
- Nicaragua
- Kidney
- Nephritis, Interstitial
- Agricultural Workers' Diseases
Dr. Mandayam's most frequent co-authors
- Wolfgang C. Winkelmayer, DSC, MD10 shared papers
- Chandan Vangala, MD8 shared papers
- Sankar Dass Navaneethan, MD4 shared papers
Recent publications by Dr. Mandayam
J Ren Nutr
Clin J Am Soc Nephrol
See who Dr. Mandayam researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Mandayam works with, so you can find a warm path to the right nephrologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Sreedhar A. Mandayam has worked on 5 clinical trials
Dmand AI links Dr. Mandayam to 5 clinical trials, 2 of them phase 4 studies. 4 are still active or recruiting. Conditions studied include Glomerulonephritis, IGA, Renal Insufficiency, Chronic and Kidney Failure, Chronic. Open Payments lists research payments to Dr. Mandayam that name 1 trial.
Clinical trials with Dr. Mandayam by phase
- NonePhase 1: no trials
- 1Phase 2: 1 trial
- 1Phase 3: 1 trial
- 2Phase 4: 2 trials
Conditions in Dr. Mandayam's trials
- Glomerulonephritis, IGA
- Renal Insufficiency, Chronic
- Kidney Failure, Chronic
- Nephritis, Hereditary
- Tumor Lysis Syndrome
Investigators on the most trials with Dr. Mandayam
- Akinwande Akinbobola Akinfolarin, MD2 shared trials
- Wesley B. Calhoun, MD2 shared trials
- Carlo Golez Castillo, DO2 shared trials
Recent clinical trials with Dr. Mandayam
A Phase 2, Open-Label, Basket Study of Atrasentan in Patients With Proteinuric Glomerular Diseases (opens in a new tab)
A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Atrasentan in Patients With IgA Nephropathy at Risk of Progressive Loss of Renal Function (opens in a new tab)
Pegloticase for the Reduction of Uric Acid in Patients With Tumor Lysis Syndrome (opens in a new tab)
Ferric Citrate in ESRD Pilot Project (opens in a new tab)
Sources: Open Payments (CMS), 2025 data, released July 7, 2026; Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Sreedhar A. Mandayam received $768,897 in industry payments from 2016 to 2025
CMS Open Payments shows 1,218 general payments to Dr. Mandayam from 51 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 45% of the total. Calliditas Therapeutics US Inc. paid the most, $222,145. It also lists 8 research payments totaling $125,579 from 2017 to 2023, naming 1 clinical trial.
General payments to Dr. Mandayam by program year, 2016 to 2025
General payments to Dr. Mandayam by kind, 2016 to 2025
- Speaker and faculty fees$346,15845%
- Honoraria$207,30427%
- Travel and lodging$93,64312%
- Consulting fees$81,73111%
- Other$40,0625%
Companies that paid Dr. Mandayam the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Sreedhar A. Mandayam has 1 award and honors on record
Dmand AI lists 1 award for Dr. Mandayam, most recently CMS Stage 1 EHR in 2013.
Awards and honors for Dr. Mandayam
- 2013
- CMS Stage 1 EHR
Source: Dmand AI Professional Profile Data
Dr. Sreedhar A. Mandayam graduated from Bangalore Medical College
Dr. Mandayam graduated from Bangalore Medical College in 1995. Dr. Mandayam is a member of ACP.
- Medical school
- Board certified in internal medicine
- Board certified in nephrology
Source: Dmand AI Professional Profile Data
Dr. Sreedhar A. Mandayam accepts plans from 14 insurance carriers
Dr. Mandayam is in network with 14 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.
- Aetna
- Blue Cross Blue Shield of Michigan
- United Healthcare
- Elevance
- HCSC
- Blue Cross Blue Shield of Massachusetts
- Regence Health Plans
- Alliant Health Plans
- +6 more carriersWith a free account
Plan types Dr. Mandayam accepts, by number of carriers
- PPO9
- HMO7
- Medicare7
- POS4
- EPO3
Source: Dmand AI Insurance Network Data
Sources for Dr. Sreedhar A. Mandayam's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Awards and committee roles | Dmand AI Professional Profile Data |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Sreedhar A. Mandayam
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Sreedhar A. Mandayam's NPI number?
Dr. Sreedhar A. Mandayam's NPI number is 1225051048. It was assigned on July 25, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Sreedhar A. Mandayam?
Dr. Sreedhar A. Mandayam is a nephrologist in Houston, Texas. The primary specialty in the NPI Registry is Nephrology Physician (taxonomy code 207RN0300X).
Where does Dr. Sreedhar A. Mandayam practice?
Dr. Mandayam practices at 1515 Holcombe Blvd, Houston, TX 77030. Dr. Mandayam's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. Dmand AI also links Dr. Mandayam to 2 medical groups.
What is Dr. Sreedhar A. Mandayam's medical license number?
Dr. Mandayam's Texas license number on file is N3861, one of the licenses on file in 10 states.
Which states has Dr. Sreedhar A. Mandayam been licensed in?
Dmand AI has state licenses on file for Dr. Mandayam in Texas (2009 to 2025), Florida (since 2021), Tennessee (2023 to 2027), Mississippi (2024 to 2026), Oklahoma (2020 to 2026), Washington (2023 to 2026), Alabama (2024 to 2025), Arizona (2023 to 2025), Georgia (2024 to 2025) and Louisiana (2023 to 2025).
Which hospitals is Dr. Sreedhar A. Mandayam affiliated with?
Dr. Mandayam practices at The University of Texas MD Anderson Cancer Center in Houston, Texas.
What medical group is Dr. Sreedhar A. Mandayam part of?
Dr. Mandayam is linked to Physicians Referral Service. Dmand AI links Dr. Mandayam to 2 more medical groups.
Does Dr. Sreedhar A. Mandayam accept Medicare?
Yes. CMS data shows Dr. Mandayam billed Medicare for 792 services in 2024, and Dr. Mandayam accepts Medicare assignment.
Does Dr. Sreedhar A. Mandayam offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Mandayam as offering telehealth services.
How many Medicare patients does Dr. Sreedhar A. Mandayam see?
CMS counts 345 Medicare patients who saw Dr. Mandayam in 2024, with an average age of 71.
Show 9 more questionsShow fewer questions
Is Dr. Sreedhar A. Mandayam board certified?
Yes. Dr. Mandayam is board certified in internal medicine by the American Board of Internal Medicine.
What services does Dr. Sreedhar A. Mandayam bill to Medicare?
In 2024, Dr. Mandayam's most billed Medicare services were hospital inpatient care (99233), hospital inpatient care (99223) and critical care (99291).
Where did Dr. Sreedhar A. Mandayam go to medical school?
Dr. Mandayam graduated from Bangalore Medical College in 1995.
What drugs does Dr. Sreedhar A. Mandayam prescribe most?
In 2024 Medicare Part D data, Dr. Mandayam's most prescribed drugs by claims were Allopurinol, Jardiance and Furosemide.
Has Dr. Sreedhar A. Mandayam received payments from drug or device companies?
CMS Open Payments shows $768,897 in general payments to Dr. Mandayam from 51 companies from 2016 to 2025. The largest total came from Calliditas Therapeutics US Inc.
How long has Dr. Sreedhar A. Mandayam been practicing?
Dr. Mandayam graduated from medical school in 1995, 31 years ago.
Does Dr. Sreedhar A. Mandayam do research?
Dmand AI links 45 publications to Dr. Mandayam, published from 2007 to 2025. Dr. Mandayam has worked on 5 clinical trials.
Who does Dr. Sreedhar A. Mandayam publish with?
Dr. Mandayam's most frequent co-authors are Wolfgang C. Winkelmayer, DSC, MD (10 shared papers), Chandan Vangala, MD (8 shared papers) and Sankar Dass Navaneethan, MD (4 shared papers).
What insurance does Dr. Sreedhar A. Mandayam accept?
Dr. Mandayam is in network with 14 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.
Selling to nephrology practices?
See nephrologists in Texas by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card